Recruiting

How a Joint Disease Medication Changes Immune Cell Patterns

Plain-English translation of NCT05782335 on ClinicalTrials.gov ↗ · Source last updated February 2026 · Translation generated June 2026 · How we translate trials

Read our Rheumatoid Arthritis research guide →

What is this trial?

Researchers want to understand how Orencia (abatacept) changes the immune system in people with rheumatoid arthritis. This study will follow three groups of people for 6 months—those starting this medication, those on other standard arthritis treatments, and healthy volunteers without arthritis—and take blood samples to see how their immune cells change over time.

Even though this medication works well for many people with rheumatoid arthritis, doctors don't fully understand exactly how it changes the immune system to reduce joint pain and swelling. This research will help explain the mechanism so that future treatments can be designed more effectively.

Do you qualify?

You likely qualify if…

you are 18 years or older and have been diagnosed with rheumatoid arthritis
you have been taking methotrexate or other standard arthritis medications at a stable dose for at least 4 weeks
you are either starting the new medication for the first time, already stable on current treatments, or are a healthy volunteer without arthritis or other autoimmune diseases
you have not previously received Orencia, rituximab, or certain other biologic medications (or stopped them long enough ago as specified)
if you are a woman of childbearing age, you are willing and able to use reliable contraception during the study

You likely don't qualify if…

you have severe complications of rheumatoid arthritis that might need immediate treatment changes, such as inflammation of the heart lining or blood vessels
you have another autoimmune disease or inflammatory condition like lupus that could interfere with the immune cell measurements
you have a serious medical condition like advanced cancer, or a body mass index below 18 or above 40
you are taking high doses of prednisone (more than 10 mg daily) or received steroid injections within 4 weeks of starting the study
you received a live vaccine within 2 weeks before the study or are unwilling to avoid live vaccines during the study

What participation looks like

If you join this study, you will visit the Hospital for Special Surgery three times over 6 months—at the beginning, at 3 months, and at 6 months. At each visit, you'll have blood drawn and answer brief questions about how you're feeling and how your arthritis is affecting your daily life. The study is designed to watch how your immune system responds to either starting the new medication, continuing your current treatment, or (if you're a healthy volunteer) serving as a comparison group.

AI-generated summary from trial data · Jun 28, 2026 · Not medical advice

Trial locations(1 site)

United States

Hospital for Special Surgery, New York, New York